Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

AWIR & ACR: Building a Strong Future Rheumatology Community

Joseph Cantrell, JD  |  August 6, 2024

The Association for Women in Rheumatology (AWIR) recently held its 2024 Annual Meeting in Orlando. AWIR once again graciously invited the ACR to exhibit and participate in the meeting. As this relationship continues to grow each year, AWIR and the ACR are working together to build a sustainable and inclusive rheumatology community for the future.

A Joint Mission

AWIR is the leading voice for women in the rheumatology community, with a primary goal of supporting the advancement and education of women in the field. The ACR and others in the rheumatology community share this goal, and we are pleased to be able to collaborate in many ways.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

The ACR and AWIR routinely engage in joint advocacy and coalition work through groups including the Voice of Rheumatology coalition and the Alliance for Transparent and Affordable Prescriptions. We have worked together on several issues confronting the rheumatology community, including utilization management reform, pharmacy benefit manager reform and addressing underwater biosimilars.

Advocacy

Advocacy has always been a key component of AWIR’s mission, which is prominently displayed during the advocacy session at the conference. This year, the panel featured two advocacy all-stars, Gwenesta Melton, MD, and Stephanie Ott, MD. Joining them on stage were Paige Colston, ACR’s manager of grassroots engagement and RheumPAC, as well as Kevin Daley and Eleni Valanos from Hart Health Strategies. The panel discussed recent developments at the state and federal levels that are impacting rheumatologists across the country.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

The panel also emphasized the importance of donating to RheumPAC, the only federal political action committee specific to rheumatology. RheumPAC plays a key role in amplifying the voice of rheumatology on Capitol Hill and beyond. AWIR has always been an enthusiastic supporter of RheumPAC and raised $5,000 from attendees at this year’s annual meeting.

Highlighting Leaders

In addition to covering rheumatology policy, the advocacy session offered the opportunity to reflect on the value of leaders. Dr. Melton and Dr. Ott have been heavily involved in AWIR, their state societies and the ACR for years. Both are volunteer leaders in the truest sense, working tirelessly in their spare time for the betterment of the rheumatology profession and their patients.

These leaders deserve recognition and praise. But they also deserve something more: for the next generation of rheumatologists to get involved and carry the flame that they, and others like them, have carried tirelessly for years.

If you have not been involved in advocacy before, I encourage you to explore the AWIR Advocacy Toolkit that Dr. Melton and Dr. Ott helped create. This is a good place to begin your advocacy journey. Now it is up to you, and I will leave you with a quote from that toolkit, by Jane Goodall: “What you do makes a difference, and you have to decide what kind of difference you want to make.”

Page: 1 2 | Single Page
Share: 

Filed under:American College of RheumatologyLegislation & Advocacy Tagged with:Association of Women in Rheumatology (AWIR)

Related Articles

    Supporting Women in Rheumatology

    September 6, 2021

    In 2014, four rheumatologists formed a new organization to promote gender equity within the field. Today, the Association of Women in Rheumatology offers training and opportunities in leadership, business development, financial planning and more, as recently highlighted at its annual meeting Aug. 12–15.

    Gwenesta B. Melton, MD, Appointed New Chair of Affiliate Society Council

    March 10, 2024

    Gwenesta B. Melton, MD, wears many hats as a rheumatologist, teacher and champion for advocacy and collaboration. She has been involved with the ASC for more than a decade.

    RheumPAC Advocacy Fund: Effecting Change

    September 16, 2021

    Professional practices, state societies and other organizations can support RheumPAC’s work with corporate funds through the RheumPAC Advocacy Fund.

    Advancing the ACR’s Legislative Priorities in 2021

    January 11, 2021

    With a new Congress and many new legislators in key leadership positions, your support today will help RheumPAC start the year off strong.

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences